OBJECTIVE: Although asthma is often inappropriately treated in children, little is known about what information pediatricians use to adjust asthma therapy. The purpose of this work was to assess the importance of various dimensions of patient asthma status as the basis of pediatrician treatment decisions. PATIENTS AND METHODS: We conducted a cross-sectional, random-sample survey, between November 2005 and May 2006, of 500 members of the American Academy of Pediatrics using standardized case vignettes. Vignettes varied in regard to (1) acute health care use (hospitalized 6 months ago), (2) bother (parent bothered by the child's asthma status), (3) control (frequency of symptoms and albuterol use), (4) direction (qualitative change in symptoms), and (5) wheezing during physical examination. Our primary outcome was the proportion of pediatricians who would adjust treatment in the presence or absence of these 5 factors. RESULTS: Physicians used multiple dimensions of asthma status other than symptoms to determine treatment. Pediatricians were significantly more likely to increase treatment for a recently hospitalized patient (45% vs 18%), a bothered parent (67% vs 18%), poorly controlled symptoms (4-5 times per week; 100% vs 18%), or if there was wheezing on examination (45% vs 18%) compared with patients who only had well-controlled symptoms. Pediatricians were significantly less likely to decrease treatment for a child with well-controlled symptoms and recent hospitalization (28%), parents who reported being bothered (43%), or a child whose symptoms had worsened since the last doctor visit (10%) compared with children with well-controlled symptoms alone. CONCLUSIONS: Pediatricians treat asthma on the basis of multiple dimensions of asthma status, including hospitalization, bother, symptom frequency, direction, and wheezing but use these factors differently to increase and decrease treatment. Tools that systematically assess multiple dimensions of asthma may be useful to help further improve pediatric asthma care.
OBJECTIVE: Although asthma is often inappropriately treated in children, little is known about what information pediatricians use to adjust asthma therapy. The purpose of this work was to assess the importance of various dimensions of patientasthma status as the basis of pediatrician treatment decisions. PATIENTS AND METHODS: We conducted a cross-sectional, random-sample survey, between November 2005 and May 2006, of 500 members of the American Academy of Pediatrics using standardized case vignettes. Vignettes varied in regard to (1) acute health care use (hospitalized 6 months ago), (2) bother (parent bothered by the child's asthma status), (3) control (frequency of symptoms and albuterol use), (4) direction (qualitative change in symptoms), and (5) wheezing during physical examination. Our primary outcome was the proportion of pediatricians who would adjust treatment in the presence or absence of these 5 factors. RESULTS: Physicians used multiple dimensions of asthma status other than symptoms to determine treatment. Pediatricians were significantly more likely to increase treatment for a recently hospitalized patient (45% vs 18%), a bothered parent (67% vs 18%), poorly controlled symptoms (4-5 times per week; 100% vs 18%), or if there was wheezing on examination (45% vs 18%) compared with patients who only had well-controlled symptoms. Pediatricians were significantly less likely to decrease treatment for a child with well-controlled symptoms and recent hospitalization (28%), parents who reported being bothered (43%), or a child whose symptoms had worsened since the last doctor visit (10%) compared with children with well-controlled symptoms alone. CONCLUSIONS: Pediatricians treat asthma on the basis of multiple dimensions of asthma status, including hospitalization, bother, symptom frequency, direction, and wheezing but use these factors differently to increase and decrease treatment. Tools that systematically assess multiple dimensions of asthma may be useful to help further improve pediatric asthma care.
Authors: R F Lemanske; C A Sorkness; E A Mauger; S C Lazarus; H A Boushey; J V Fahy; J M Drazen; V M Chinchilli; T Craig; J E Fish; J G Ford; E Israel; M Kraft; R J Martin; S A Nachman; S P Peters; J D Spahn; S J Szefler Journal: JAMA Date: 2001 May 23-30 Impact factor: 56.272
Authors: Jill S Halterman; H Lorrie Yoos; Jeffrey M Kaczorowski; Kenneth McConnochie; Robert J Holzhauer; Kelly M Conn; Sherri Lauver; Peter G Szilagyi Journal: Arch Pediatr Adolesc Med Date: 2002-02
Authors: Alexander N Ortega; Peter J Gergen; A David Paltiel; Howard Bauchner; Kathleen D Belanger; Brian P Leaderer Journal: Pediatrics Date: 2002-01 Impact factor: 7.124
Authors: Jill S Halterman; Kenneth M McConnochie; Kelly M Conn; H Lorrie Yoos; Jeffrey M Kaczorowski; Robert J Holzhauer; Marjorie Allan; Peter G Szilagyi Journal: Ambul Pediatr Date: 2003 Mar-Apr
Authors: Sande O Okelo; Michelle N Eakin; Cecilia M Patino; Alvin P Teodoro; Andrew L Bilderback; Darcy A Thompson; Antonio Loiaza-Martinez; Cynthia S Rand; Shannon Thyne; Gregory B Diette; Kristin A Riekert Journal: J Allergy Clin Immunol Date: 2013-02-21 Impact factor: 10.793
Authors: Sande O Okelo; Michelle N Eakin; Kristin A Riekert; Alvin P Teodoro; Andrew L Bilderback; Darcy A Thompson; Antonio Loiaza-Martinez; Cynthia S Rand; Shannon Thyne; Gregory B Diette; Cecilia M Patino Journal: J Allergy Clin Immunol Pract Date: 2014-01-17
Authors: Sande O Okelo; Kristin A Riekert; Michelle N Eakin; Andrew L Bilderback; Gregory B Diette; Cynthia S Rand; Gayane Yenokyan Journal: J Asthma Date: 2013-12-06 Impact factor: 2.515
Authors: Cecilia M Patino; Sande O Okelo; Cynthia S Rand; Kristin A Riekert; Jerry A Krishnan; Kathy Thompson; Ruth I Quartey; Deanna Perez-Williams; Andrew Bilderback; Barry Merriman; Laura Paulin; Nadia Hansel; Gregory B Diette Journal: J Allergy Clin Immunol Date: 2008-10-11 Impact factor: 10.793
Authors: Sande O Okelo; George K Siberry; Barry S Solomon; Andrew L Bilderback; Michiyo Yamazaki; Theresa Hetzler; Cynthia L Ferrell; Nui Dhepyasuwan; Janet R Serwint Journal: Acad Pediatr Date: 2014-03-12 Impact factor: 3.107